A panel of federal advisers might vote early subsequent 12 months on new suggestions concerning the nation's blood provide, the Biden administration says, in one of many key remaining hurdles to ending a sweeping federal ban on blood donations from sexually energetic homosexual males.
The vote anticipated on the spring assembly of the Advisory Committee on Blood and Tissue Security and Availability (ACBTSA) would come after the panel is ready to overview forthcoming information from the Meals and Drug Administration's ADVANCE Examine.
The FDA introduced final week that it now thinks the examine's outcomes "will probably assist" changing the blanket ban, which at the moment requires homosexual males to abstain from intercourse for a minimum of three months earlier than donating blood. The Advance examine has been trying on the effectiveness of utilizing blood financial institution screening questionnaires to display screen potential donors based mostly on their particular person danger components, as a substitute of broad "time-based deferrals."
"This committee has performed, and can proceed to play an energetic function, in deferral insurance policies. On the spring ACBTSA assembly subsequent 12 months, the committee will probably vote on a suggestion, after reviewing the info from the Advance Examine," a spokesperson for the Division of Well being and Human Companies tells CBS Information.
An FDA spokesperson mentioned Monday that the company will seek the advice of the committee "as applicable" as it really works to "decide subsequent steps."
If the committee subsequent 12 months backs lifting the restrictions, the transfer would mark one of many final steps to undoing a controversial coverage, first launched within the Nineteen Eighties and endorsed by the panel as just lately as 2010, which had imposed a lifetime ban on homosexual males donating blood.
The lifetime ban was decreased in 2015 to permit donating blood after abstaining from intercourse for 12 months, after which down to a few months in 2020.
Whereas blood banks are actually capable of run exams to display screen for HIV, there may be nonetheless a danger that the virus might be missed in the course of the "window interval" early in an individual's an infection.
"So now the Advance Examine has completed enrolling, and everybody may be very anxious to see the outcomes, the evaluation of the examine," says Dr. Claudia Cohn, director of the College of Minnesota's Blood Financial institution Laboratory.
Cohn can be chief medical officer for the Affiliation for the Development of Blood and Biotherapies (AABB), which represents the blood transfusion subject, and chair of the ACBTSA.
"On the subject of information and blood security, FDA is extraordinarily and appropriately conservative. They are not going to let something change except they've very, very excessive stage of confidence that blood security is not going to be negatively affected," mentioned Cohn.
A committee of AABB consultants has been drafting a possible mannequin for what the brand new risk-assessment questionnaires would possibly appear to be, based mostly on comparable standards that was adopted by Canada earlier this 12 months.
A considerable revision to the AABB's questionnaire is already underneath overview by the FDA for approval, which addresses whether or not donors are taking medicines, referred to as PrEP, to stop HIV an infection. That might intrude with the power of blood banks to check donations for HIV.
The present Canadian questionnaire additionally consists of questions on HIV PrEP medicine, in addition to dozens of inquiries to gauge HIV danger, starting from the variety of companions as to if individuals have had intercourse with a intercourse employee.
Different questions in Canada's screening embody asking whether or not potential donors have just lately had anal intercourse, and if they've had new or a number of sexual companions previously few months.
"AABB has been engaged on this donor historical past questionnaire for some time, in preparation for this, however is not going to transfer on it till we all know the outcomes of the Advance Examine and what the FDA desires to do," Cohn mentioned.
The FDA has but to verify precisely which questions have been tried in its examine. An AABB spokesperson additionally declined to touch upon the questions within the examine. The regulator says it checked out "comparable danger components which were addressed by different nations," however declined to disclose specifics.
"In an effort to take care of neutrality, objectivity and impartiality all through the examine, the questions used as a part of the examine remained confidential. Additional info shall be obtainable as soon as FDA's evaluation of the examine outcomes are full," an FDA spokesperson mentioned.
Additionally it is unclear how a lot ending the ban would do to enhance the nation's blood provide, which has confronted shortfalls lately.
The American Purple Cross in an announcement mentioned that it does "not have any information to point out that a coverage change would lead to extra blood donations." In January, the group had declared a dire first-ever "blood disaster" amid the worst scarcity in over a decade.
That scarcity has now been resolved, although the group warned seasonal shortages might proceed to happen with out extra individuals giving blood regularly.
Preliminary findings from the Nationwide Blood Assortment and Utilization Survey, offered at a November AABB assembly, means that blood assortment "will preserve tempo with blood utilization necessities."